Results 201 to 210 of about 587,245 (265)
GLP-1 Receptor Agonist Associated Unmasking of Insulinoma. [PDF]
Simonov E +4 more
europepmc +1 more source
Gluteal hemangioma mimicking a neuroendocrine tumor: pitfalls in neuroendocrine tumor diagnostic testing. [PDF]
Braunstein GD +5 more
europepmc +1 more source
Incidental cystic pancreatic neuroendocrine neoplasm and differential diagnosis. [PDF]
Martin D +7 more
europepmc +1 more source
Pathogenesis of nonfamilial somatotroph adenomas.
Ben-Shlomo A, Melmed S.
europepmc +1 more source
VIPoma Presenting With Obstructive Jaundice: A Case Report. [PDF]
Ng SY, Chiew KS.
europepmc +1 more source
Comprehensive Clinicopathologic, Immunohistochemical, and Genomic Profiling of Sporadic Ampullary Somatostatin-producing D-cell Neuroendocrine Tumors Identifies Recurrent HRAS Hotspot Mutations. [PDF]
Vanoli A +16 more
europepmc +1 more source
Decoding Brain Development and Function Through GABAergic Inhibitory Neurons. [PDF]
Batista-Brito R +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Digestion, 2000
Somatostatin is a neuropeptide produced by neuroendocrine, inflammatory and immune cells in response to different stimuli. Somatostatin inhibits various cellular functions including secretions, motility and proliferation. Its action is mediated by five specific somatostatin receptors (sst1-sst5) which belong to the G protein-coupled receptor family ...
N, Benali +4 more
openaire +2 more sources
Somatostatin is a neuropeptide produced by neuroendocrine, inflammatory and immune cells in response to different stimuli. Somatostatin inhibits various cellular functions including secretions, motility and proliferation. Its action is mediated by five specific somatostatin receptors (sst1-sst5) which belong to the G protein-coupled receptor family ...
N, Benali +4 more
openaire +2 more sources
Trends in Endocrinology and Metabolism, 1985
It is now well established that the biological actions of tetradecapeptide somatostatin (somatostatin-14, S-14) are receptor-mediated. These receptors were first quantified in GH4C pituitary tumor cells using [125I-Tyr1] S-14 as radioligand which was found to exhibit high non-specific binding to membrane receptor preparations from normal tissues.
Y C, Patel, C B, Srikant
openaire +3 more sources
It is now well established that the biological actions of tetradecapeptide somatostatin (somatostatin-14, S-14) are receptor-mediated. These receptors were first quantified in GH4C pituitary tumor cells using [125I-Tyr1] S-14 as radioligand which was found to exhibit high non-specific binding to membrane receptor preparations from normal tissues.
Y C, Patel, C B, Srikant
openaire +3 more sources

